Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 34   

Articles published

AGEN 3.18 +0.04 (1.27%)
price chart
Morning Buzz: Agenus Inc. (NASDAQ:AGEN), Banco Santander (NYSE:BSBR ...
Agenus Inc. (NASDAQ:AGEN) an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, announced that Robert Stein, MD, PhD, the company's Chief Scientific Officer, will speak at ...
5 Stocks Under Wall Street's Radar : Agenus Inc. (NASDAQ:AGEN), Salesforce ...
On JULY 25, Agenus Inc. (NASDAQ:AGEN) was a big mover last session, as the company saw its shares shoot up over 11% on the day.
Today's Hot List: Agenus Inc. (NASDAQ:AGEN), iSoftStone Holdings Limited ...
On 24 JULY Agenus Inc. (NASDAQ:AGEN) announced its financial results and business highlights for the second quarter ended June 30, 2014.
Today's Stocks: Agenus Inc. (NASDAQ:AGEN), United Continental Holdings ...
Agenus Inc. (NASDAQ:AGEN) on 24 July announced net loss attributable to common stockholders for the second quarter of 2014 was $7.7 million, or $0.12 per share, basic and diluted, compared to a net loss attributable to common stockholders of $11.2 ...
Shining on Major News: Regions Financial Corporation (NYSE:RF), Agenus Inc ...
On July 24, 2014, Agenus Inc. (NASDAQ:AGEN) an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, announced its financial results and business highlights for ...
Hot News: Intel Corporation (NASDAQ:INTC), Agenus Inc. (NASDAQ:AGEN ...
On July 25, Agenus Inc. (NASDAQ:AGEN) was a big mover last session, as the company saw its shares shoot up over 11% on the day.
Related articles »  
5 Stocks Under Wall Street's Radar: Planar Systems Inc. (NASDAQ:PLNR ...
Agenus Inc. (NASDAQ:AGEN) on 24 July announced net loss attributable to common stockholders for the second quarter of 2014 was $7.7 million, or $0.12 per share, basic and diluted, compared to a net loss attributable to common stockholders of $11.2 ...
Related articles »  
Agenus to Participate in Two Upcoming Investor Conferences
LEXINGTON, Mass., Sep 02, 2014 (BUSINESS WIRE) -- Agenus Inc. AGEN, +1.27% an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced that ...
Related articles »  
Why Agenus (AGEN) Could Be Positioned for a Slump
One such stock that you may want to consider dropping is Agenus Inc. (AGEN - Snapshot Report), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the ...
Agenus to Present at Cambridge Healthtech Institute'sSecond Annual ...
LEXINGTON, Mass., Aug 04, 2014 (BUSINESS WIRE) -- Agenus Inc. AGEN, -0.32% an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced that Robert Stein, MD, ...
Related articles »